LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

Search

Omnicell Inc

Ouvert

SecteurSoins de santé

32.77 2.34

Résumé

Variation du prix de l'action

24h

Actuel

Min

32.02

Max

32.79

Chiffres clés

By Trading Economics

Revenu

13M

5.6M

Ventes

21M

291M

P/E

Moyenne du Secteur

66.18

35.724

BPA

-0.151

Marge bénéficiaire

1.941

Employés

3,650

EBITDA

42M

30M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+30.06% upside

Dividendes

By Dow Jones

Prochains Résultats

29 oct. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

162M

1.5B

Ouverture précédente

30.43

Clôture précédente

32.77

Sentiment de l'Actualité

By Acuity

50%

50%

167 / 371 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Omnicell Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

2 sept. 2025, 23:07 UTC

Acquisitions, Fusions, Rachats

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

2 sept. 2025, 22:10 UTC

Principaux Mouvements du Marché

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

2 sept. 2025, 21:47 UTC

Résultats

Alimentation Couche-Tard Logs Lower Profit, Revenue in 1Q

2 sept. 2025, 16:52 UTC

Principaux Mouvements du Marché

CleanCore Solutions Shares Drop After $175 Million Private Investment

2 sept. 2025, 22:47 UTC

Market Talk

Google, Apple Can Grow AI Deal With Lawsuit Resolved -- Market Talk

2 sept. 2025, 21:40 UTC

Acquisitions, Fusions, Rachats

Investors Have to Be Ready for State Capitalism. What Areas to Watch. -- Barrons.com

2 sept. 2025, 21:07 UTC

Résultats

Couche-Tard 1Q U.S. Same-Store Merchandise Revenue Up 0.4% >ATD.T

2 sept. 2025, 21:07 UTC

Résultats

Couche-Tard 1Q Canada Same-Store Merchandise Revenue Up 4.1% >ATD.T

2 sept. 2025, 21:05 UTC

Résultats

Couche-Tard 1Q Rev $17.35B >ATD.T

2 sept. 2025, 21:05 UTC

Résultats

Couche-Tard 1Q Adj EPS 78c >ATD.T

2 sept. 2025, 21:05 UTC

Résultats

Couche-Tard 1Q EPS 82c >ATD.T

2 sept. 2025, 21:05 UTC

Résultats

Couche-Tard 1Q Net $782.5M >ATD.T

2 sept. 2025, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

2 sept. 2025, 20:53 UTC

Market Talk
Acquisitions, Fusions, Rachats

Knight-Swift Transportation Endorses Union Pacific, Norfolk Southern Merger -- Market Talk

2 sept. 2025, 20:51 UTC

Acquisitions, Fusions, Rachats

Buffett Dislikes Breakup of Kraft Heinz. It's Been One of His Worst Investments. -- Barrons.com

2 sept. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

2 sept. 2025, 20:27 UTC

Résultats

NIO Stock Rises After Second-Quarter Loss Narrows -- Barrons.com

2 sept. 2025, 20:24 UTC

Acquisitions, Fusions, Rachats

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

2 sept. 2025, 20:18 UTC

Acquisitions, Fusions, Rachats

Procter & Gamble Does Not Endorse Tutanota's Unsolicited Mini-Tender Offer >PG

2 sept. 2025, 20:17 UTC

Acquisitions, Fusions, Rachats

Procter & Gamble: Tutanota Says It Expects to Extend Offer for Successive Periods of Up to 180 Days Until Market Price Exceeds Offer Price >PG

2 sept. 2025, 20:16 UTC

Acquisitions, Fusions, Rachats

Procter & Gamble: 'Shareholders Who Tender Their Shrs in the Offer Will Receive a Below-Market Price' >PG

2 sept. 2025, 20:16 UTC

Acquisitions, Fusions, Rachats

Procter & Gamble: Offer by Tutanota Is to Purchase Up to 500,000 Shrs at $128 Each

2 sept. 2025, 20:15 UTC

Acquisitions, Fusions, Rachats

Procter & Gamble Has Been Notified of Unsolicited Mini-Tender Offer by Tutanota >PG

2 sept. 2025, 19:55 UTC

Résultats

GM Had a Record Month of EV Sales. A 'Collapse' Is Coming. -- Barrons.com

2 sept. 2025, 19:50 UTC

Acquisitions, Fusions, Rachats

Food Giants Are Struggling. Could Mergers, Spinoffs, and Activist Stakes Help? -- Barrons.com

2 sept. 2025, 19:09 UTC

Market Talk

Oil Futures Gain on Geopolitical Premium -- Market Talk

2 sept. 2025, 19:00 UTC

Market Talk

U.S. Natural Gas Futures Recover $3 Level -- Market Talk

2 sept. 2025, 18:12 UTC

Market Talk

Gold Pushes To New Record -- Market Talk

2 sept. 2025, 17:04 UTC

Market Talk

Philip Morris Riding Smoke-Free Products to Higher Margins -- Market Talk

2 sept. 2025, 16:57 UTC

Acquisitions, Fusions, Rachats

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

Comparaison

Variation de prix

Omnicell Inc prévision

Objectif de Prix

By TipRanks

30.06% hausse

Prévisions sur 12 Mois

Moyen 41.75 USD  30.06%

Haut 55 USD

Bas 32 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

6 ratings

4

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

24.23 / 30.44Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

167 / 371Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.